Skip to content

Baxter International Inc

BAX· NYSECore metricsCIK 10456

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · -2.28%
Market cap
$13.31B
517.35M shares
Filings
1,042
$2.98B
Q3 2026+5.7% FY25 yoy
$294.00M
Q3 2026N/M FY25 yoy
$225.00M
Q3 2026N/M FY25 yoy
$332.00M
FY 2025derived−42.1% FY25 yoy
$0.57
Q3 2026N/M FY25 yoy
$1.98B
Q3 2026+11.5% FY25 yoy
$13.31B
—
1.1×
2.0×
—
0.77%

Twelve months to Sep 30, 2026 · derived

Price

$25.73+40.99%+$7.48past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$11.24BFY 2025
$12.15B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$11,244,000,000reported
FY 20242024-12-31$10,636,000,000reported
FY 20232023-12-31$10,360,000,000 revisedreported
FY 20222022-12-31$10,057,000,000 revisedreported
FY 20212021-12-31$12,146,000,000 revisedreported
FY 20202020-12-31$11,673,000,000reported
FY 20192019-12-31$11,362,000,000reported
FY 20182018-12-31$11,099,000,000 revisedreported
FY 20172017-12-31$10,584,000,000 revisedreported
FY 20162016-12-31$10,163,000,000reported
FY 20152015-12-31$9,968,000,000reported
FY 20142014-12-31$10,719,000,000 revisedreported

Capital returns

Dividends and buybacks · FY2014 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$348.00M—$348.00M$0.52514.49M sh+0.6%104.8%
FY2024$590.00M$0.00$590.00M$1.04511.62M sh+0.7%103.0%
FY2023$586.00M$0.00$586.00M$1.16507.83M sh+0.6%45.3%
FY2022$573.00M$32.00M$605.00M$1.15504.67M sh+0.5%72.5%
FY2021$530.00M$600.00M$1.13B$1.09502.29M sh−0.6%73.8%

Segments

Revenue by Segments, FY2018 to FY2025FY2018APAC · FY2018 · $2.20BAmericas · FY2018 · $5.95BEMEA · FY2018 · $2.95BFY2019APAC · FY2019 · $2.30BAmericas · FY2019 · $6.31BEMEA · FY2019 · $2.76BFY2020APAC · FY2020 · $2.48BAmericas · FY2020 · $6.32BEMEA · FY2020 · $2.88BFY2021Medical Products & Therapies · FY2021 · $4.82BHealthcare Systems & Technologies · FY2021 · $212.00MPharmaceuticals · FY2021 · $2.29BAPAC · FY2021 · $2.79BAmericas · FY2021 · $6.67BEMEA · FY2021 · $3.12BHillrom · FY2021 · $212.00MKidney Care · FY2021 · $4.68BFY2022Medical Products & Therapies · FY2022 · $4.82BHealthcare Systems & Technologies · FY2022 · $2.94BPharmaceuticals · FY2022 · $2.13BAPAC · FY2022 · $2.59BAmericas · FY2022 · $6.71BEMEA · FY2022 · $2.88BHillrom · FY2022 · $2.94BKidney Care · FY2022 · $4.45BFY2023Medical Products & Therapies · FY2023 · $5.01BHealthcare Systems & Technologies · FY2023 · $3.01BPharmaceuticals · FY2023 · $2.25BKidney Care · FY2023 · $4.45BFY2024Medical Products & Therapies · FY2024 · $5.21BHealthcare Systems & Technologies · FY2024 · $2.95BPharmaceuticals · FY2024 · $2.41BFY2025Medical Products & Therapies · FY2025 · $5.30BHealthcare Systems & Technologies · FY2025 · $3.07BPharmaceuticals · FY2025 · $2.49B
LineFY2025ShareChange
Medical Products & Therapies$5.30B47%+1.8%
Healthcare Systems & Technologies$3.07B27%+4.1%
Pharmaceuticals$2.49B22%+3.4%
APAC———
Americas———
EMEA———
Hillrom———
Kidney Care———
Total$11.24B

From the 10-K filed Feb 12, 2026BAX

Surgical & medical instruments & apparatus

Baxter International Inc is the 6th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Baxter International Inc · CIK 10456 · Engraved from SEC EDGAR